Supplementary Table for Real-World Efficacy of Upadacitinib in a Diverse Alopecia Areata Cohort: A Retrospective Study
收藏Mendeley Data2026-04-18 收录
官方服务：
资源简介：
Supplementary Table
应用场景：
创建时间：
2026-04-20
相关数据集
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis
This study was an open-label, clinical trial to investigate tofacitinib 5 mg to 10 mg PO twice daily in the treatment of moderate/severe alopeica areata and to identify if gene expression of the scalp
NIAID Data Ecosystem70
Supplemental Material: Real-world efficacy of ritlecitinib in treating alopecia areata across various anatomical sites: Potential rapid response predictors
This real-world study aimed to evaluate the effectiveness and safety of ritlecitinib in a heterogeneous cohort of AA patients and identify response in scalp as well as lashes, brows and nails, and cli
Mendeley Data20
Ritlecitinib in Alopecia Areata: A Multicenter Retrospective Real-World Analysis
Supplemental Figure 1 detailing the SALT score changes before and after treatment discontinuation in 11 patients. Supplemental Table 1 detailing the demographic characteristics of all patients and Sup
NIAID Data Ecosystem00
Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
Although compound glycyrrhizin (CG) has been widely used to alopecia areata (AA) in China, its efficacy and safety remain unclear. This systematic review and meta-analysis aimed to evaluate the effica
Taylor & Francis Group2025-12-21 更新30
Supplementary Material - Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib
Supplementary Materials - Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
Mendeley Data20
